NeueHealth (NYSE:NEUE – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($2.29) per share and revenue of $261.80 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
NeueHealth Stock Performance
Shares of NeueHealth stock opened at $5.10 on Wednesday. The firm has a fifty day moving average of $7.16 and a two-hundred day moving average of $6.01. The stock has a market capitalization of $42.25 million, a price-to-earnings ratio of -0.10 and a beta of 0.56. NeueHealth has a 52 week low of $3.79 and a 52 week high of $7.66.
Analysts Set New Price Targets
Separately, Royal Bank of Canada decreased their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.
Insider Activity
In related news, CEO George Lawrence Mikan III sold 31,798 shares of the company’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $233,079.34. Following the completion of the transaction, the chief executive officer now directly owns 146,539 shares of the company’s stock, valued at approximately $1,074,130.87. This represents a 17.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total transaction of $29,979.52. Following the completion of the transaction, the chief financial officer now directly owns 41,592 shares of the company’s stock, valued at approximately $280,330.08. The trade was a 9.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 110,033 shares of company stock valued at $774,560 in the last quarter. Company insiders own 64.30% of the company’s stock.
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Stories
- Five stocks we like better than NeueHealth
- What Are Some of the Best Large-Cap Stocks to Buy?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Must-Own Stocks to Build Wealth This Decade
- The Most Important Warren Buffett Stock for Investors: His Own
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.